Live from the NIH registry
Studies recruiting near Spartanburg right now
Top 25 of 358 recruiting studies, sorted by proximity — each links to its official registry page
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Prisma Health Cancer Institute - Spartanburg — Boiling Springs, South Carolina (7.8 mi)
· Sponsor: SWOG Cancer Research Network
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma
Phase 2
Interventional 396 participants sought
Prisma Health Cancer Institute - Spartanburg — Boiling Springs, South Carolina (7.8 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Phase 4
Interventional 300 participants sought
Carolina Nephrology PA — Spartanburg, South Carolina (0.5 mi)
· Sponsor: Amgen
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (27.3 mi)
· Sponsor: National Cancer Institute (NCI)
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Greenville, South Carolina (27.3 mi)
· Sponsor: AstraZeneca
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Triple Negative Breast Cancer, HER2-negative Breast Cancer
Phase 1
Interventional 96 participants sought
Dren Investigational Site — Greenville, South Carolina (27.3 mi)
· Sponsor: Dren Bio
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Spartanburg Medical Center — Spartanburg, South Carolina (0.5 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Prisma Health Cancer Institute - Spartanburg — Boiling Springs, South Carolina (7.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
Levine Cancer Institute - Rutherford — Forest City, North Carolina (27.1 mi)
· Sponsor: Canadian Cancer Trials Group
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
Actinic Keratosis
Phase 3
Interventional 160 participants sought
Palmetto Clinical Trial Services, LLC — Greenville, South Carolina (27.3 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Healthy
Phase 3
Interventional 6,000 participants sought
Tribe Clinical Research, LLC- Greer — Greer, South Carolina (17.1 mi)
· Sponsor: Pfizer
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
Rhinovirus Infection
Phase 2
Interventional 180 participants sought
Velocity Clinical Research - Spartanburg — Spartanburg, South Carolina (0.5 mi)
· Sponsor: Altesa Biosciences, Inc.
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (27.3 mi)
· Sponsor: National Cancer Institute (NCI)
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Carolina Ottobock.care — Spartanburg, South Carolina (0.5 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Prisma Health Cancer Institute - Spartanburg — Boiling Springs, South Carolina (7.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 798 participants sought
Prisma Health-Upstate Cancer Institute — Greenville, South Carolina (27.3 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Systemic Lupus Erythematosus
Phase 3
Interventional 100 participants sought
Research Site — Greenville, South Carolina (27.3 mi)
· Sponsor: AstraZeneca
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Extensive Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma, A Subtype
Phase 2
Interventional 900 participants sought
Prisma Health Cancer Institute - Spartanburg — Boiling Springs, South Carolina (7.8 mi)
· Sponsor: SWOG Cancer Research Network
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Spartanburg, South Carolina (0.5 mi)
· Sponsor: Medtronic
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
Saint Francis Health System ( Site 0089) — Greenville, South Carolina (27.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
Saint Francis Hospital — Greenville, South Carolina (27.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Sickle Cell Disease
Phase 2, Phase 3
Interventional 389 participants sought
Prisma Health Greer Memorial Hospital — Greer, South Carolina (17.1 mi)
· Sponsor: Pfizer
A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
Psoriasis
Phase 4
Interventional 45 participants sought
Bausch Site 05 — Spartanburg, South Carolina (0.5 mi)
· Sponsor: Bausch Health Americas, Inc.
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
Supratentorial Hemorrhage
N/A
Observational 500 participants sought
Prisma Health - Upstate — Greenville, South Carolina (27.3 mi)
· Sponsor: Integra LifeSciences Corporation
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Carolina Nephrology, PA — Spartanburg, South Carolina (0.5 mi)
· Sponsor: Dimerix Bioscience Pty Ltd